1
|
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.
|
Lancet
|
2002
|
10.52
|
2
|
Evaluating patient-based outcome measures for use in clinical trials.
|
Health Technol Assess
|
1998
|
9.32
|
3
|
Cost-benefit analysis of long-term haemodialysis for chronic renal failure.
|
Br Med J
|
1975
|
3.87
|
4
|
Modelling in economic evaluation: an unavoidable fact of life.
|
Health Econ
|
1997
|
3.40
|
5
|
Variations in GP night visiting rates: medical organisation and consumer demand.
|
Br Med J
|
1977
|
3.24
|
6
|
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening.
|
Br J Surg
|
2012
|
2.55
|
7
|
The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.
|
Pharmacoeconomics
|
1993
|
2.26
|
8
|
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
|
Lancet
|
1998
|
1.94
|
9
|
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.
|
BMJ
|
2007
|
1.81
|
10
|
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial.
|
Lancet
|
1994
|
1.78
|
11
|
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy.
|
Diabet Med
|
1991
|
1.55
|
12
|
Radiology report times: impact of picture archiving and communication systems.
|
AJR Am J Roentgenol
|
1998
|
1.55
|
13
|
The benefits of hospital-wide picture archiving and communication systems: a survey of clinical users of radiology services.
|
Br J Radiol
|
1999
|
1.47
|
14
|
Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies.
|
Health Econ
|
1992
|
1.46
|
15
|
Distribution of hospital provision: policy themes and resource variations.
|
Br Med J
|
1975
|
1.42
|
16
|
Assessing the costs of healthcare technologies in clinical trials.
|
Health Technol Assess
|
1999
|
1.39
|
17
|
Population characteristics and the distribution of general medical practitioners.
|
Br Med J
|
1979
|
1.28
|
18
|
Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis.
|
J Chronic Dis
|
1987
|
1.27
|
19
|
How cost-effective is screening for abdominal aortic aneurysms?
|
J Med Screen
|
2007
|
1.14
|
20
|
The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?
|
Qual Life Res
|
1994
|
1.14
|
21
|
Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm.
|
Br J Surg
|
2008
|
1.13
|
22
|
Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions.
|
Health Technol Assess
|
1998
|
1.12
|
23
|
Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness.
|
Health Technol Assess
|
2013
|
1.01
|
24
|
Identifying the impact of diabetes research.
|
Diabet Med
|
2006
|
0.97
|
25
|
Health-related quality of life following liver transplantation.
|
Qual Life Res
|
1998
|
0.92
|
26
|
A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris.
|
Eur J Cardiothorac Surg
|
2001
|
0.91
|
27
|
Examining the influence of picture archiving communication systems and other factors upon the length of stay for patients with total hip and total knee replacements.
|
Int J Technol Assess Health Care
|
1999
|
0.91
|
28
|
The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
|
Heart
|
2007
|
0.86
|
29
|
An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure.
|
J Clin Epidemiol
|
1990
|
0.84
|
30
|
Economic forces and hospital technology. A perspective from Europe.
|
Int J Technol Assess Health Care
|
1987
|
0.83
|
31
|
Anti-coagulant monitoring service delivery: a comparison of costs of hospital and community outreach clinics.
|
Clin Lab Haematol
|
2000
|
0.82
|
32
|
Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial.
|
Trials
|
2008
|
0.81
|
33
|
Relationship between functional status and health-related quality-of-life after myocardial infarction.
|
Med Care
|
1993
|
0.79
|
34
|
Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in England.
|
Br J Surg
|
2014
|
0.76
|
35
|
Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusion.
|
BMJ
|
1989
|
0.75
|
36
|
Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis.
|
Br Heart J
|
1992
|
0.75
|
37
|
Population screening for abdominal aortic aneurysm.
|
J Public Health Med
|
1994
|
0.75
|
38
|
Cost-effectiveness as a guide to pricing a new pharmaceutical product.
|
S Afr Med J
|
1994
|
0.75
|
39
|
Explaining variation in radiologists' reporting times.
|
Br J Radiol
|
1995
|
0.75
|
40
|
Managing new technology: economics research and practical decisions.
|
Health Serv Manage Res
|
1988
|
0.75
|
41
|
Assessing low volume, high cost, potentially life saving surgical interventions: how and when? Left ventricular assist devices (LVADs) as a case study.
|
J Eval Clin Pract
|
1999
|
0.75
|
42
|
Letter: The cost of death.
|
Lancet
|
1975
|
0.75
|
43
|
What is the cost of primary care and who pays the bill? Cost constraints and financial incentives.
|
Ann N Y Acad Sci
|
1978
|
0.75
|
44
|
Economic evaluation of treatments for respiratory disease.
|
Pharmacoeconomics
|
1992
|
0.75
|